EP3270890
Sýklóspórínsamsetningar til notkunar við að fyrirbyggja eða meðhöndla þráláta höfnun lungnaígræðslu
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
15.3.2016EP published:
13.9.2023EP application number:
16711565.8
EP translation filed:
21.11.2023Grant published:
15.12.2023EPO information:
European Patent Register
Max expiry date:
14.3.2036Expiry date:
14.3.2027Next due date:
31.3.2027
Title in English:
CYCLOSPORINE FORMULATIONS FOR USE IN THE PREVENTION OR TREATMENT OF PULMONARY CHRONIC GRAFT REJECTIONLanguage of the patent:
English
Timeline
Today
15.3.2016EP application
13.9.2023EP Publication
21.11.2023Translation submitted
15.12.2023Registration published
14.3.2027Expires
Owner
Name:
Breath Therapeutics GmbHAddress:
Aldringenstr. 4, 80639 München, DE
Inventor
Name:
KNOCH, MartinAddress:
82467 Garmisch-Partenkirchen, DE
Name:
DENK, OliverAddress:
82541 Münsing, DE
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
15020035Date:
16.3.2015Country:
EP
Classification
Categories:
A61K 38/13, A61P 37/06, A61K 9/00, A61K 47/26, A61K 9/127, A61K 9/19
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 13.3.2024
Expires: 14.3.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 10
Paid: 4.3.2025
Expires: 14.3.2026
Payer: Árnason Faktor ehf.
Number: 11
Paid: 11.3.2026
Expires: 14.3.2027
Payer: G.H. Sigurgeirsson ehf.